Edwards Lifesciencesvs.ResMed
EW vs RMD · both in Medtech & devices, part of the Medicine, pharma & life science value chain: Medical equipment and devices, from surgery and cardiology to robotics.
Edwards Lifesciences is about 1.6× larger than ResMed by market cap; ResMed trades at the lower P/E (21.5 vs 53.5); year to date, Edwards Lifesciences leads (+6.2% vs −3.5%).
Side by side
| EW | RMD | |
|---|---|---|
| Market cap | $53.8B | $32.7B |
| Price | $90.87 | $236.59 |
| Today | +0.4% | +1.8% |
| Return YTD | +6.2% | −3.5% |
| Return 1Y | +10.6% | −20.9% |
| P/E | 53.5 | 21.5 |
| P/S | 8.3 | 5.8 |
| P/B | 5.1 | 5.0 |
Data as of 2026-08-26 · updates daily after U.S. close
The two companies
Edwards LifesciencesEW
Heart valves, delivered by catheter as with TAVR or implanted surgically.
Full EW profile →ResMedRMD
CPAP machines and masks for sleep apnea, sold with cloud software, next to a wider respiratory equipment range.
Full RMD profile →More EW & RMD comparisons
Other head-to-heads in the Medtech & devices segment.
See where EW and RMD sit in the full Medicine, pharma & life science map: every segment from suppliers to end markets.Open the Life science value chain →